Balthaser Kevin
Insider CIK 1957554 · ACRS Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2026-03-01 | 2026-03-03 | 2,375 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2026-03-01 | 2026-03-03 | 2,375 | — | $0 | 188,130 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2026-03-01 | 2026-03-03 | 677 | $2.87 | $1.9K | 187,453 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2026-02-03 | 2026-02-05 | 22,025 | — | $0 | 66,075 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2026-02-03 | 2026-02-05 | 6,449 | $3.47 | $22.4K | 185,755 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2026-02-03 | 2026-02-05 | 22,025 | — | $0 | 192,204 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2026-02-02 | 2026-02-06 | 346,800 | — | $0 | 346,800 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2026-02-02 | 2026-02-06 | 99,100 | — | $0 | 99,100 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2026-02-01 | 2026-02-03 | 14,750 | — | $0 | 29,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2026-02-01 | 2026-02-03 | 14,750 | — | $0 | 175,163 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2026-02-01 | 2026-02-03 | 4,984 | $3.51 | $17.5K | 170,179 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2026-01-02 | 2026-01-05 | 13,200 | — | $0 | 13,600 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2026-01-02 | 2026-01-05 | 13,200 | — | $0 | 164,874 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2026-01-02 | 2026-01-05 | 4,461 | $2.88 | $12.8K | 160,413 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2026-01-01 | 2026-01-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2026-01-01 | 2026-01-05 | 7,500 | — | $0 | 153,924 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2026-01-01 | 2026-01-05 | 2,250 | $3.01 | $6.8K | 151,674 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2025-12-31 | 2026-01-05 | 73,750 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2025-12-31 | 2026-01-05 | 19,934 | $3.01 | $60.0K | 146,424 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2025-12-31 | 2026-01-05 | 73,750 | — | $0 | 166,358 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2025-03-01 | 2025-03-04 | 2,375 | — | $0 | 2,375 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2025-03-01 | 2025-03-04 | 1,100 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2025-03-01 | 2025-03-04 | 1,100 | — | $0 | 90,960 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2025-03-01 | 2025-03-04 | 2,375 | — | $0 | 93,335 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2025-03-01 | 2025-03-04 | 727 | $1.99 | $1.4K | 92,608 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2025-02-03 | 2025-02-04 | 308,200 | — | $0 | 308,200 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2025-02-03 | 2025-02-04 | 88,100 | — | $0 | 88,100 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2025-02-01 | 2025-02-04 | 14,750 | — | $0 | 44,250 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2025-02-01 | 2025-02-04 | 14,750 | — | $0 | 95,676 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2025-02-01 | 2025-02-04 | 5,816 | $2.48 | $14.4K | 89,860 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2025-01-02 | 2025-01-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2025-01-02 | 2025-01-03 | 13,200 | — | $0 | 26,800 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2025-01-02 | 2025-01-03 | 5,059 | $2.48 | $12.5K | 80,926 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2025-01-02 | 2025-01-03 | 13,200 | — | $0 | 85,985 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2025-01-01 | 2025-01-03 | 7,500 | — | $0 | 15,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2025-01-01 | 2025-01-03 | 7,500 | — | $0 | 75,215 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2025-01-01 | 2025-01-03 | 2,430 | $2.48 | $6.0K | 72,785 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-12-31 | 2025-01-03 | 73,750 | — | $0 | 73,750 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2024-12-31 | 2025-01-03 | 30,732 | $2.48 | $76.2K | 67,715 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-12-31 | 2025-01-03 | 73,750 | — | $0 | 98,447 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-09-01 | 2024-09-04 | 1,000 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2024-09-01 | 2024-09-04 | 286 | $1.18 | $337 | 24,697 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-09-01 | 2024-09-04 | 1,000 | — | $0 | 24,983 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-03-02 | 2024-03-05 | 1,500 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2024-03-02 | 2024-03-05 | 427 | $1.24 | $529 | 23,983 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-03-02 | 2024-03-05 | 1,500 | — | $0 | 24,410 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-03-01 | 2024-03-05 | 2,375 | — | $0 | 4,750 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-03-01 | 2024-03-05 | 1,100 | — | $0 | 1,100 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2024-03-01 | 2024-03-05 | 677 | $1.24 | $839 | 22,910 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-03-01 | 2024-03-05 | 2,375 | — | $0 | 23,587 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2024-03-01 | 2024-03-05 | 313 | $1.24 | $388 | 21,212 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-03-01 | 2024-03-05 | 1,100 | — | $0 | 21,525 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 206,500 | — | $0 | 206,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 147,500 | — | $0 | 147,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 59,000 | — | $0 | 59,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-01-01 | 2024-01-03 | 7,500 | — | $0 | 22,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-01-01 | 2024-01-03 | 7,500 | — | $0 | 22,961 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2024-01-01 | 2024-01-03 | 2,536 | $1.05 | $2.7K | 20,425 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | P Buy | 2023-09-06 | 2023-09-07 | 9,490 | $7.90 | $75.0K | 15,461 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2023-09-01 | 2023-09-05 | 1,000 | — | $0 | 1,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2023-09-01 | 2023-09-05 | 1,000 | — | $0 | 6,256 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2023-09-01 | 2023-09-05 | 285 | $7.90 | $2.3K | 5,971 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2023-03-03 | 2023-03-03 | 894 | $12.63 | $11.3K | 5,256 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2023-03-02 | 2023-03-03 | 1,500 | — | $0 | 1,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2023-03-02 | 2023-03-03 | 1,000 | $12.29 | $12.3K | 4,650 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2023-03-02 | 2023-03-03 | 1,500 | — | $0 | 6,150 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2023-03-01 | 2023-03-03 | 2,375 | — | $0 | 7,125 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2023-03-01 | 2023-03-03 | 1,100 | — | $0 | 2,200 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2023-03-01 | 2023-03-03 | 1,475 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2023-03-01 | 2023-03-03 | 2,375 | — | $0 | 5,650 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2023-03-01 | 2023-03-03 | 1,475 | — | $0 | 2,175 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2023-03-01 | 2023-03-03 | 1,100 | — | $0 | 3,275 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2023-02-01 | 2023-02-03 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2023-02-01 | 2023-02-03 | 105,000 | — | $0 | 105,000 | SEC↗ |